Product NDC: | 13533-635 |
Proprietary Name: | GamaSTAN S/D |
Non Proprietary Name: | Immune Globulin (Human) |
Active Ingredient(s): | .165 g/mL & nbsp; Immune Globulin (Human) |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13533-635 |
Labeler Name: | Grifols Therapeutics Inc. |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA101134 |
Marketing Category: | BLA |
Start Marketing Date: | 19960814 |
Package NDC: | 13533-635-02 |
Package Description: | 10 VIAL in 1 CARTON (13533-635-02) > 2 mL in 1 VIAL (13533-635-40) |
NDC Code | 13533-635-02 |
Proprietary Name | GamaSTAN S/D |
Package Description | 10 VIAL in 1 CARTON (13533-635-02) > 2 mL in 1 VIAL (13533-635-40) |
Product NDC | 13533-635 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | Immune Globulin (Human) |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 19960814 |
Marketing Category Name | BLA |
Labeler Name | Grifols Therapeutics Inc. |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Strength Number | .165 |
Strength Unit | g/mL |
Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |